PyInvesting

Market research

TECH Bio-Techne Corp

NASDAQ USD Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
11B
P/E ratio
62.35
Analyst target
70.7273
Dividend yield
0.4%
Beta
1.28

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 4 months ago

Bio-Techne Corporation is currently in a long term uptrend where the price is trading 26.8% above its 200 day moving average.

From a valuation standpoint, the stock is 98.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 19.8.

Bio-Techne Corporation's total revenue rose by 21.3% to $224M since the same quarter in the previous year.

Its net income has dropped by 52.9% to $56M since the same quarter in the previous year.

Finally, its free cash flow grew by 137.9% to $133M since the same quarter in the previous year.

Based on the above factors, Bio-Techne Corporation gets an overall score of 4/5.